PeptideStack
5.2kquestions
20kanswers
220users

What would you ask Zhuhai Kerui Biotechnology before a first order that they cannot fake?

Asked 6 Feb 2025Modified 15 months agoViewed 24k times
33

I have certificates from two lots and an independent result on one of them.

I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.

Assume no laboratory access beyond what I can pay a third party for.

Concretely, what should I do, and how would I know afterwards whether I did it right?

vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
shareeditfollowflag
VR
askedv_ramaswamy68k576 Feb 2025

5 Answers

Sorted by votes
30

The honest answer is that a small first order tested independently beats any amount of reading, and it costs less than most people expect.

Ask what happens if a result comes back outside specification. The answer is informative regardless of what it is, and the question itself tells you something about how it lands.

Cost per milligram, adjusted honestly

StepValueNote
Vial price, 10 mg nominal£34.00As advertised
Nominal cost per mg£3.4034 ÷ 10
Measured content9.2 mgIndependent content assay
Cost per actual mg£3.7034 ÷ 9.2
Dead-space loss, 20 draws4 %80 µL of a 2 mL fill
Cost per delivered mg£3.853.70 ÷ 0.96
First vial, with £110 assay£14.85Testing dominates a single vial

Independent submission costs a fraction of a mid-sized order at any of the services this community uses, and it converts an opinion into a number attached to your own material.

The caveat is that a good result on one lot is a fact about that lot. It is a prior for the next one, not a guarantee.

Ask for the lot-specific certificate before ordering. It is free and it is decisive.

shareimprove this answerflag
TM
answeredtobias_maartens171k35811 Apr 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
21

The short version: ask for the lot-specific certificate, check the method section, check the lot code ties to a vial, then spend a small amount and test it yourself.

The post-arrival sequence: inspect before reconstitution, photograph anything unexpected, confirm the lot code is physically on the vial, and submit a sample to an independent laboratory before committing to a larger order.

The single most informative free test is asking for the certificate of the lot they intend to ship and then confirming, on arrival, that the code on the glass matches it. A supplier who can do that has a traceability system; one who cannot does not.

Two lots agreeing is worth more than one lot excelling.

edited 16 Apr 2025 by tobias_maartens — updated for the 2026 guidance change

shareimprove this answerflag
TM
answeredtobias_maartens171k35831 Mar 2025
Worth flagging that comparing across laboratories is comparing laboratories, not suppliers. – micron22 2 months ago
2Confirming that a small first order plus one independent submission is the cheapest route. – Dr_Rosalind_Achebe 4 months ago
add a comment
17

Reputation is a prior. An independent result on your own vial is the evidence.

The pre-order sequence: request a lot-specific certificate for the exact line, check that it names a lot code rather than a batch family, check that it carries the column, gradient and detection wavelength, and check the analysis date is recent relative to the lot.

Repeat the exercise on a second lot months later. Lot-to-lot agreement is the property that actually predicts your next order, and it cannot be established from one submission.

The independent testing services this community references — Janoshik, Medutest, PeptideMeter and VendorInvestigate — publish results that can be searched by supplier, compound and date, which makes prior lots checkable.

Testing narrows uncertainty. It does not turn research-grade material into something with release testing behind it.

Small first order, independent submission, then scale. In that order.

shareimprove this answerflag
KA
answeredkwn_analytical147k3584 May 2025
4Does the same reasoning hold for a group order, where one lot covers everybody? – charge_state_3 3 months ago
add a comment
14

On the detail: a certificate without a method section is a claim rather than a measurement, and that distinction does most of the work here.

Set your accept threshold before you see the result. Deciding after the number arrives is how thresholds become negotiable, and everybody does it unless they wrote it down first.

Published inter-laboratory comparisons of peptide purity routinely find spreads of half a per cent to a per cent on identical material, which sets a realistic expectation for agreement.

A supplier link on this site is marked nofollow and sponsored and is not a recommendation; it is there so a claim can be checked against its source.

Match the code on the glass to the code on the certificate. Everything else is secondary.

shareimprove this answerflag
WC
answeredwren_calloway23k3823 Apr 2025
12

The relevant principle is that a supplier's reputation tells you about other people's lots and a certificate tells you about yours.

Published third-party data on a named lot is worth more than any aggregate rating, because it is about a specific object rather than about an average of other people's objects.

Purity by RP-HPLC and quantified content are separate measurements answering separate questions, and only the second one tells you how many milligrams are in the vial.

Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.

Write your accept threshold down before the result arrives.

shareimprove this answerflag
TM
answeredtobias_maartens171k35826 Feb 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.